You prove my point in another post of mine @Mom88. Biotechs have been sold down horrendously over the last few years and will always be able to raise money if they have viable IP. I can see Osteopore is just one of many biotechs which may rise substially in the future once their products are approved.
You prove my point in another post of mine @Mom88. Biotechs have...
Add OSX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $6.135M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 6.5¢ | 5.3¢ | $100.7K | 1.744M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 586 | 5.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.8¢ | 23329 | 1 |
View Market Depth
| Last trade - 13.04pm 05/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.6¢ |
Change
0.003 ( 6.67 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 6.5¢ | 5.3¢ | 764045 | ||
| Last updated 12.49pm 05/06/2024 ? | |||||
| OSX (ASX) Chart |